These results strongly suggest that glioblastoma cells may have the ability to develop a mechanism(s) which would allow for either (1) the silencing of wild-type P53 transcription, (2) the degradation of wild-type P53 mRNA, or (3) the selective overproduction of mutated P53 mRNA. Here, TP53 is linked to glioblastoma.